Levobupivacaine wound infiltration — Competitive Intelligence Brief

Levobupivacaine wound infiltration (Levobupivacaine wound infiltration) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide). Area: Anesthesia/Pain Management.

marketed Local anesthetic (amide) Voltage-gated sodium channels Anesthesia/Pain Management Small molecule

Target snapshot

Levobupivacaine wound infiltration (Levobupivacaine wound infiltration) — University of Genova. Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Levobupivacaine wound infiltration TARGET	Levobupivacaine wound infiltration	University of Genova	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Ropivacaine 2 %	Ropivacaine 2 %	Hospital Ambroise Paré Paris	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
ropivacaïne 0,5 %	ropivacaïne 0,5 %	Nantes University Hospital	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
ropivacaine (Naropin)	ropivacaine (Naropin)	University of Zurich	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Ropivicaine with Epinephrine	Ropivicaine with Epinephrine	Health Sciences North Research Institute	marketed	Local anesthetic with vasoconstrictor	Voltage-gated sodium channels
Ropivacaine 0.2% Injectable Solution	Ropivacaine 0.2% Injectable Solution	University of Minnesota	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Ropivacaine 0.2% for PENG Block	Ropivacaine 0.2% for PENG Block	Poznan University of Medical Sciences	marketed	Local anesthetic (amide)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide) class)

1. Poznan University of Medical Sciences · 4 drugs in this class
2. Nantes University Hospital · 3 drugs in this class
3. Bozyaka Training and Research Hospital · 2 drugs in this class
4. ASST Gaetano Pini-CTO · 2 drugs in this class
5. Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
6. Chiang Mai University · 1 drug in this class
7. Beijing Tiantan Hospital · 1 drug in this class
8. Complejo Hospitalario Universitario de Granada · 1 drug in this class
9. Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
10. China Medical University, China · 1 drug in this class